Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
The Journal of Surgical Research
|
April 15, 2026
Efficacy of Triclosan-Coated Barbed Sutures for Fascial Closure in Colorectal Surgery
Yoh Kitamura, Shingo Tsujinaka, Tomoya Miura, et al.
International Journal of Clinical Oncology
|
July 2, 2022
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data
Kentaro Sawada, Daisuke Kotani, Hiroki Yukami, et al.
The Oncologist
|
May 29, 2021
A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)
Yasuyuki Kawamoto, Hiroshi Nakatsumi, Kazuaki Harada, et al.
Journal of Gastrointestinal Oncology
|
July 25, 2017
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
Tetsuhito Muranaka, Masaki Kuwatani, Yoshito Komatsu, et al.
BMC Surgery
|
August 10, 2019
Influence of age on postoperative complications especially pneumonia after gastrectomy for gastric cancer
Chikashi Shibata, Hitoshi Ogawa, Toru Nakano, et al.
Gastrointestinal Endoscopy
|
November 14, 2021
Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion
Daiki Sato, Tomohiro Kadota, Atsushi Inaba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 25, 2014
[Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer]
Susumu Sogabe, Takahiro Tateno, Masataka Yagisawa, et al.
Cancer Medicine
|
February 19, 2022
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study
Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 30, 2019
[A Resected Case of Cancer in the Ileum of the Blind Loop after an Ileotransverse Colostomy]
Akinobu Yasuyama, Fumito Saijo, Naoki Matsumura, et al.
ESMO Open
|
July 29, 2020
Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer
Akinori Sasaki, Akihito Kawazoe, Testuya Eto, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
The Journal of Surgical Research
|
April 15, 2026
Efficacy of Triclosan-Coated Barbed Sutures for Fascial Closure in Colorectal Surgery
Yoh Kitamura, Shingo Tsujinaka, Tomoya Miura, et al.
International Journal of Clinical Oncology
|
July 2, 2022
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data
Kentaro Sawada, Daisuke Kotani, Hiroki Yukami, et al.
The Oncologist
|
May 29, 2021
A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)
Yasuyuki Kawamoto, Hiroshi Nakatsumi, Kazuaki Harada, et al.
Journal of Gastrointestinal Oncology
|
July 25, 2017
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
Tetsuhito Muranaka, Masaki Kuwatani, Yoshito Komatsu, et al.
BMC Surgery
|
August 10, 2019
Influence of age on postoperative complications especially pneumonia after gastrectomy for gastric cancer
Chikashi Shibata, Hitoshi Ogawa, Toru Nakano, et al.
Gastrointestinal Endoscopy
|
November 14, 2021
Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion
Daiki Sato, Tomohiro Kadota, Atsushi Inaba, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 25, 2014
[Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer]
Susumu Sogabe, Takahiro Tateno, Masataka Yagisawa, et al.
Cancer Medicine
|
February 19, 2022
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study
Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 30, 2019
[A Resected Case of Cancer in the Ileum of the Blind Loop after an Ileotransverse Colostomy]
Akinobu Yasuyama, Fumito Saijo, Naoki Matsumura, et al.
ESMO Open
|
July 29, 2020
Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer
Akinori Sasaki, Akihito Kawazoe, Testuya Eto, et al.
Page
of 6